MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • MDS Virtual Congress 2021

    Metabolic patterns and neurodegeneration in isolated REM sleep behavior disorder

    JH. Shin, JY. Lee, YK. Kim, HJ. Kim, EJ. Yoon, HW. Nam, B. Jeon (Seoul, Republic of Korea)

    Objective: To elucidate the role of Parkinson’s disease (PD)-related brain metabolic patterns as a biomarker in isolated rapid-eye-movement sleep behavior disorder (iRBD) for clinical correlation…
  • MDS Virtual Congress 2021

    Longitudinal 18F-PBR06 (TSPO) and Volumetric MR Imaging as Pharmacodynamic Endpoints for MSA – Ongoing Investigator Sponsored Trial of Verdiperstat

    T. Singhal, A. Pitaro, J. Kim, J. Woods, M. Mesidor, J. Ficke, A. Willett, S. Cicero, K. O'Connor, I. Qureshi, G. Young, V. Khurana (Boston, USA)

    Objective: In multiple system atrophy (MSA) patients to: 1) evaluate 18F-PBR06 positron emission tomography (PET) for longitudinal assessment of 18-kilodalton-translocator protein (TSPO) binding; 2) assess…
  • MDS Virtual Congress 2021

    Persistent and efficient transduction of the putamen following gene therapy for aromatic L-amino acid decarboxylase deficiency

    Y. Onuki, S. Ono, T. Nakajima, K. Kojima, N. Taga, K. Kawai, T. Sato, S. Muramatsu, T. Yamagata (Yakushiji, Japan)

    Objective: This study aimed to evaluate longitudinal transduction in subcortical regions and transduction of the cortico-putaminal network after putaminal AADC gene therapy. Background: Aromatic L-amino…
  • MDS Virtual Congress 2021

    Language impairment in Corticobasal Syndrome: from clinical phenotype to biomarkers

    J. Parmera, M. Oliveira, A. Coutinho, I. de Almeida, C. Carneiro, A. Neto, R. Nitrini, C. Buchpiguel, E. Barbosa, S. Brucki (São Paulo, Brazil)

    Objective: To investigate the language impairment profile of patients diagnosed as probable Corticobasal Syndrome (CBS) [1] in light of a multimodal imaging biomarkers analysis, namely…
  • MDS Virtual Congress 2020

    Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease

    G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

    Objective: To investigate the relationship between ventral striatum D3 dopamine receptor availability and severity of impulse control disorder (ICD) in Parkinson’s disease (PD). Background: Reduced…
  • MDS Virtual Congress 2020

    In vivo imaging of presynaptic terminal loss in early Parkinson’s disease

    A. Delva, D. Van Weehaeghe, M. Koole, K. Van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To determine the magnitude and anatomical extent of presynaptic terminal damage in early Parkinson’s disease (PD) in vivo, we performed a PET study with…
  • MDS Virtual Congress 2020

    Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson’s disease

    G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

    Objective: To investigate with PET and the radioligand [11C]PHNO whether levodopa-induced dyskinesias in Parkinson disease (PD) are associated with dopamine-D3 receptor (D3R) overexpression in substantia nigra…
  • MDS Virtual Congress 2020

    Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)

    Objective: Objective: The aim of this study was to evaluate the correlation between the location of active contacts and weight gain after subthalamic nucleus deep…
  • MDS Virtual Congress 2020

    Mechanisms of chronic neuroleptic-induced parkinsonism examined with positron emission tomography

    M. Galoppin, P. Berroir, J. Soucy, E. Stip, P. Blanchet (Montreal, QC, Canada)

    Objective: To investigate the cause of chronic neuroleptic drug-induced parkinsonism (NIP) through examination of the profile of striatal monoaminergic nerve terminal density using positron emission…
  • MDS Virtual Congress 2020

    Dopaminergic denervation in de-novo Parkinson’s disease. Does functional somatotopy plays a role?

    J.A Pineda-Pardo, A. Sánchez-Ferro, M. HM Monje, J.A Obeso (Móstoles, Spain)

    Objective: To clarify how dopaminergic denervation occurs along the dorsoventral axis of the posterior putamen in the earliest stages of PD. Background: Dopamine loss in…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley